Loading...
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering condition that can lead to cardiovascular calcification, metabolic bone disease (renal osteodystrophy) and the development of secondary hyperparathyroidism (SHPT). It is also associated with increased prevalenc...
Na minha lista:
| Udgivet i: | Saudi Pharm J |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4908098/ https://ncbi.nlm.nih.gov/pubmed/27330380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsps.2015.01.009 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|